Pablo Antúnez-Muiños: PLATEBRISK Study – Review of Simplified Antithrombotic Regimen after LAAO
EuroIntervention shared on X:
”The PLATEBRISK study suggests that a simplified antithrombotic regimen after LAAO is as effective as conventional treatment for high bleeding risk patients, with a lower rate of major bleeding in those with a history of bleeding. Pablo Antúnez-Muiños”
Article: A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study
Authors: Pablo Antúnez-Muiños, Sergio López-Tejero, Pedro Cepas-Guillén, Matias Mon-Noboa, Juan M. Ruiz-Nodar, Luis Andrés-Lalaguna, Fernando Rivero, Juan Gabriel Córdoba-Soriano, Ignacio J. Amat-Santos, Berenice Caneiro-Queija, David Martí Sánchez, Javier Jimeno Sánchez, Fernando Torres Mezcua, Fabián Blanco-Fernández, Jorge Sanz Sánchez, Cristina Moreno-Ambroj, Rodrigo Estévez-Loureiro, Luis Nombela-Franco, Xavier Freixa-Rofastes, Ignacio Cruz-González
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!